Loading
A phase 2 trial of High-dose intravenous vitamin C in Non-Hodgkin lymphoma, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, recorded as terminated on the registry.
Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL) is a phase 2 interventional study registered as NCT00626444 by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, with 2 participants recorded, started 2008-02 and due to reach its primary completion in 2011-12. Interventions recorded: Intravenous vitamin C. Conditions recorded: Non-Hodgkin Lymphoma.
Linked to the technology High-dose intravenous vitamin C because the registry's title names it ("high dose intravenous vitamin c") and Non-Hodgkin lymphoma among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares High-dose intravenous vitamin C and the tag pipeline.
Shares High-dose intravenous vitamin C and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/